Ethos Life: Why This Insurance Platform Stock Has Doubled — And What the Factor Stack Actually Says

Ethos Life stock has roughly doubled since January, surging from its $19 IPO price to nearly $40. William Blair recently named it the top pick in insurance, calling the growth durable and the valuation still reasonable. The stock has compounded 110% year-to-date and 234% over the past four months.

The rally is real. The question is whether the factor stack that drove it is still intact, or whether valuation has caught up and the rest is coasting.

And to answer that, you first need to understand what Ethos actually is — because it is not the kind of company you compare to Cincinnati Financial or MetLife. That is not a distinction of preference. It is a distinction of economics.

An asset-light platform, not an insurance carrier

Ethos does not underwrite life insurance risk. It does not hold a book of policies, reserve for claims, or carry the interest-rate exposure that burdens traditional insurers. Instead, it operates a digital platform that connects consumers and agents with six carrier partners — Aflac, Ameritas, Banner Life, North American, Protective, and TruStage — who hold 100% of the risk. Ethos collects commissions, fees, and administrative revenue for matching buyers to policies.

The margin structure reflects that model. Gross profit in the most recent quarter was $185.5 million on $189.6 million of revenue — a 98% gross margin. There is no underwriting loss, no claims reserve volatility, no surplus strain. Ethos earns its revenue the way a payment processor or software platform does, which is why the company's unit economics and growth rate belong in a different comparison set than the P/E-7, dividend-paying traditional insurers.

That said, the platform model carries its own structural risk. Three carriers generated 88% of Ethos's 2025 revenue. The business is not diversified across its partners, and any change in a key carrier relationship or compensation structure would be immediately material. Management co-develops proprietary products with carriers rather than distributing generic products, which deepens both the partnership and the concentration.

The growth factor: A+ by any measure

Revenue grew 113% year-over-year in Q2 fiscal 2026 to $189.6 million, the second consecutive quarter above 100% growth. Full-year guidance sits at $727-731 million, implying 88% growth for the fiscal year that ends in January 2027. The company activated 107,847 new policies in Q2 alone — it took 54 months to reach the first 100,000, and three months to add the next 100,000.

The growth is split between two channels. Direct-to-consumer revenue grew 131% to $116.5 million, driven by more than doubling advertising spend while maintaining consistent unit economics and improving sequential return on ad spend. The third-party agent channel grew 90% to $73.1 million, accelerating from 42% in Q1. Management projects the third-party mix could approach 50% of total revenue as agent recruitment compounds.

The Rule of 40 score — revenue growth plus EBITDA margin — hit 132% in Q2. For context, a score above 40% separates fast growers who also generate cash from those that burn it to scale. Ethos is not just above the threshold. It is an outlier.

Profitability: the split between adjusted and GAAP

Here is where the picture requires careful reading. On a non-GAAP basis, Ethos generated $35 million of net income in Q2, an 18% margin. Adjusted EBITDA was $35.2 million at a 19% margin. Operating cash flow came in at $35.7 million, including an $8 million timing benefit from a carrier settlement expected to reverse in Q3.

On a GAAP basis over the trailing twelve months, the company posts a net loss. Stock-based compensation surged to $195.5 million in Q1 fiscal 2026 alone, up from $9.8 million in the prior-year period — a function of the IPO equity grant structure. The result: TTM GAAP net margin of -21% and a negative P/E multiple.

The gap between GAAP and non-GAAP is wide, but it is a known post-IPO pattern rather than hidden expense. Stock-based compensation is real dilution, and it compresses as the grant pool matures. The more useful question is whether the underlying operating economics — contribution profit of 33% margin, $381.5 million in commission receivables representing future policy cash flows, and positive free cash flow of $71 million TTM — are durable as the company scales. Management's answer, reinforced by the $100 million share buyback authorization, is yes.

Valuation: expensive by traditional standards, growth-priced by tech standards

At $39.85, Ethos trades at a market cap of $2.5 billion and an enterprise value of $2.4 billion — the company holds $112 million in cash against $220 million in debt, leaving essentially zero net debt. The price-to-sales ratio stands at 4.3x on trailing revenue, and the PEG ratio is 0.21.

William Blair estimated 2027 EV/EBITDA at 16x, below comparable growth companies. That estimate assumes management's full-year adjusted EBITDA guidance of $119-123 million holds, and that the company does not materially miss the 88% revenue growth path. If both hold, the forward multiple is not extreme for a company growing at this rate with this margin profile.

But forward multiples require forward execution. The stock has priced in not just the current acceleration but sustained growth, margin maintenance, successful annuity expansion, and the third-party channel reaching 50% revenue mix. That is a lot of assumption packed into $2.5 billion.

Compare that to Cincinnati Financial, which trades at a 7.9x P/E, 1.6x P/B, and pays a 2.1% dividend — a different business entirely, but the comparison illustrates what "cheap" means in the insurance sector. Ethos is not cheap by sector standards. It is growth-priced, and the growth better keep coming.

Momentum and technicals: hot, at the margin

The stock's RSI sits at 70.8 — at the threshold of overbought. The 50-day moving average is at $26.71, and the current price of $39.85 is well above it, confirming a strong uptrend. Volume was 1.04 million shares on a recent session, with a turnover rate of 8.2%. The stock traded as high as $41 within its 52-week range, which started at $9.45.

Momentum is strong. That is the good news and the risk in the same breath. A stock up 234% in four months does not have the same risk-reward as one that is just starting to move. Momentum confirms the thesis but reduces the margin of safety for new entrants.

Where it fits — and what would change it

Every stock in a watch list needs a portfolio role. Ethos belongs in a growth sleeve, not a value sleeve or an income sleeve. It is the kind of name you hold when you are comfortable with concentrated, high-growth exposure in the financial services sector and you understand the difference between platform economics and traditional insurance. It hedges against the idea that insurance is only a slow-growing, dividend-yielding business — and it is itself hedged by the traditional insurers in the same sector that trade at single-digit multiples.

The factor trajectory over the past three months has been unidirectionally positive: growth accelerating, profitability turning to non-GAAP income, momentum compounding, and the $100 million buyback providing a management-backed floor signal. That said, three things would degrade the rating:

• Revenue growth deceleration below 50% would suggest the advertising-fueled acquisition engine is losing efficiency, and the growth premium in the multiple would compress.
• Carrier concentration risk materializing — a disruption to one of the three dominant partners would be an immediate earnings event given the 88% revenue dependency.
• Contribution margin erosion — if the shift toward third-party agents and whole life products pushes the 33% contribution margin structurally lower, the Rule of 40 advantage narrows and the valuation loses its anchor.

The bar is high because the market has already priced a lot of optimism into this stock. But the underlying numbers — 98% gross margins, 113% revenue growth, 132% Rule of 40, positive free cash flow, and a $100 million buyback on a $2.5 billion company — are not typical insurance numbers. They are platform numbers. And if you are going to own a growth name in insurance, you want the one that behaves like a platform, not the ones that still look like 19th-century balance sheets.